Abstract Body

Tuberculosis is a leading cause of maternal mortality, especially among women living with HIV. Women are most likely to develop active tuberculosis during and immediately after pregnancy. But the prevention and management of tuberculosis during pregnancy remain contentious, and national guidelines vary widely owing to insufficient data. This presentation will review: (1) The global burden of tuberculosis in women of reproductive age; (2) How pregnancy and the postpartum period affect M. tuberculosis immunology in women with and without HIV; (3) How to screen and treat pregnant women for tuberculosis infection, including data on isoniazid preventive therapy, rifapentine-containing regimens, and potential drug-drug interactions with antiretrovirals; (4) How to diagnose and treat pregnant women for tuberculosis disease, including drug-resistant tuberculosis; and (5) High-priority research areas for tuberculosis research in pregnant and postpartum women.